OTC Markets EXMKT - Delayed Quote USD
Histogen Inc. (HSTO)
At close: November 6 at 3:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CASHION CHARLES J Chief Financial Officer | Conversion of Exercise of derivative security | Jan 9, 2017 | 187,162 |
| KISNER DANIEL L Director | Purchase | Apr 8, 2015 | 7,145 |
| MARSHALL KEITH W. Chief Operating Officer | Conversion of Exercise of derivative security | May 22, 2020 | 19,885 |
| MENTO STEVEN J Director | Conversion of Exercise of derivative security | May 22, 2020 | 82,280 |
| PASCOE RICHARD W Chief Executive Officer | Purchase | Mar 30, 2021 | 30,000 |
| RIPLEY DANIEL L. Officer | Stock Award(Grant) | Nov 14, 2018 | -- |
| SMITH EDWARD F III Officer | Stock Award(Grant) | Nov 14, 2018 | 10,875 |
| SPADA ALFRED P Officer | Conversion of Exercise of derivative security | May 22, 2020 | 44,309 |
| VAN WART HAROLD E. PH.D. Director | Conversion of Exercise of derivative security | Oct 27, 2016 | 18,181 |
| VANDERTIE MICHELLE L Officer | Stock Gift | May 30, 2017 | -- |
Related Tickers
6C1.F CytomX Therapeutics, Inc.
0.8400
+7.35%
6JH.SG IN8bio Inc
0.3060
+0.66%
6C1.BE CytomX Therapeutics Inc
0.9330
+0.54%
BT1.F BioSenic S.A.
0.0065
-43.48%
SFY0.MU Theriva Biologics Inc. R
1.3600
0.00%
6C1.SG CytomX Therapeutics Inc
0.9095
-1.57%
T3X.SG Telix Pharmaceuticals Ltd
13.79
+1.06%
6JH.F IN8bio, Inc.
0.3060
-7.27%
6C1.DU CytomX Therapeutics Inc
0.9150
-0.92%
APTA.L Aptamer Group plc
0.2401
+4.39%